2020 Archives - Keystoneheart

29 Jul 2020 Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device

Posted at 08:45h in by keyheart41 0 Comments

TAMPA, Fla., July 29, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care, today announced completion of the first worldwide commercial case using the TriGUARD 3™ Cerebral Embolic Protection (CEP) Device. Pieter Stella, MD, Assistant Professor, Medical Department of...

16 Jun 2020 Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.

Posted at 09:09h in by keyheart41 0 Comments

0 Likes

TAMPA, Fla., June 16, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care, today announced it has acquired 510 Kardiac Devices, Inc., a privately-held medical device company and makers of the Lim Transseptal System. The Lim Transseptal System was designed...

10 Mar 2020 TriGUARD 3™ Cerebral Embolic Protection Device Receives CE Mark for Use in Transcatheter Heart Procedures

Posted at 05:29h in by keyheart41 0 Comments

0 Likes

TAMPA, Fla., March 10, 2020 /PRNewswire/ -- Keystone Heart Ltd., a Venus Medtech Company, today announced European CE Mark for the TriGUARD 3™ Cerebral Embolic Protection (CEP) Device. The device is designed to minimize the risk of cerebral damage by deflecting embolic debris away from cerebral circulation during...

press-category

press-category

29 Jul 2020 Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device

16 Jun 2020 Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.

10 Mar 2020 TriGUARD 3™ Cerebral Embolic Protection Device Receives CE Mark for Use in Transcatheter Heart Procedures

A Venus Medtech Company

Important Links

Disclaimer